Organigram Global (OGI) Enterprise Value (2018 - 2026)
Organigram Global (OGI) posted quarterly Enterprise Value of $33.1 million for Q1 2026, down 31.53% year-on-year from $48.3 million in Q1 2025, and down 1.88% on a QoQ basis from $33.7 million in Q4 2025.
Organigram Global (OGI) Enterprise Value (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Enterprise Value for 9 consecutive years, with $33.1 million the latest figure, recorded in Q1 2026.
- Quarterly Enterprise Value fell 31.53% year-over-year to $33.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.1 million (down 49.71% YoY) and the FY2025 annual result came in at $33.7 million, changed N/A from the prior year.
- Enterprise Value declined to $33.1 million in Q1 2026 per OGI's latest filing, from $33.7 million in the prior quarter.
- Over the last five years, Enterprise Value for OGI reached as high as $48.3 million in Q1 2025 and fell as low as -$97.2 million in Q3 2024.
- A 5-year average of -$5.6 million and a median of -$1.7 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value tumbled 151.78% — and 2025, when it surged 93.1%.
- Year by year, Enterprise Value stood at -$20.8 million in 2022, then slumped by 85.38% to -$38.6 million in 2023, then surged by 145.22% to $17.5 million in 2024, then jumped by 93.1% to $33.7 million in 2025, then fell by 1.88% to $33.1 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $33.1 million, $33.7 million, and -$21.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 33.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.08 Mn |
| Dec 31, 2025 | 33.71 Mn |
| Sep 30, 2025 | -21.09 Mn |
| Mar 31, 2025 | 48.31 Mn |
| Dec 31, 2024 | 17.46 Mn |
| Sep 30, 2024 | -97.21 Mn |
| Sep 30, 2023 | -38.61 Mn |
| Aug 31, 2022 | -20.83 Mn |
| Nov 30, 2021 | -69.01 Mn |
| Aug 31, 2021 | -183.56 Mn |
| May 31, 2021 | -169.16 Mn |
| Feb 28, 2021 | -71.12 Mn |
| Nov 30, 2020 | -133.90 Mn |
| Aug 31, 2020 | -56.11 Mn |
| May 31, 2020 | -32.02 Mn |
| Feb 29, 2020 | -41.24 Mn |
| Aug 31, 2019 | -287,429.99 |
| Aug 31, 2018 | -55.06 Mn |